Official Title
Assessment of Lung Functions in Menopausal Obese Women After COVID 19 Recovery
Brief Summary

The COVID-19 pandemic has presented considerable challenges to global health services and dictates almost every aspect of medical practice and policy. The menopausal transition may have significant consequences for respiratory health as COVID 19 symptoms subsides, lung function testing should be done to assess the consequences of this virus on lung health especially in menopausal woman.

Detailed Description

The study group will consist of (40) obese menopausal women whom were recently recovered from
mild-moderate COVID 19 for one month. The control group will consist of (40) obese menopausal
women; whom will not affected by COVID 19. Using incentive spirometer, we will measure forced
vital capacity FVC, forced expiratory volume FEV, Tiffano index TI and peak expiratory force
PEF in both groups.

Completed
Lung Function Decreased
Obesity
Menopause
COVID19

Device: Spirometry

Spirometry assesses the integrated mechanical function of the lung, chest wall, respiratory muscles, and airways by measuring the total volume of air exhaled from a full lung (total lung capacity [TLC]) to maximal expiration (residual volume [RV]). This volume, the forced vital capacity (FVC) and the forced expiratory volume in the first second of the forceful exhalation (FEV1), should be repeatable to within 0.15 L upon repeat efforts in the same measurement unless the largest value for either parameter is less than 1 L. In this case, the expected repeatability is to within 0.1 L of the largest value.

Eligibility Criteria

Inclusion Criteria:

- Participants recovered from mild to moderated signs and symptoms of COVID- 19 after
one month.

- Ability to perform pulmonary function tests correctly.

- COVID-19 was diagnosed by positive polymerase chain reaction (PCR) testing on
nasopharyngeal swab, oxygen saturation was ranged between 92-96% during illness
period.

- CT chest shows ground glass opacity.

- Their D-dimer was less than 0.5 μg/ml.

- Two successive negative PCR were before included in study.

- Participants were in home isolation during illness period.

Exclusion Criteria:

- Chronic respiratory disease.

- Chronic heart disease.

- Diabetes mellitus.

- Smoking.

- Centralized isolation.

- Severe COVID-19.

Eligibility Gender
Female
Eligibility Age
Minimum: 45 Years ~ Maximum: 55 Years
Countries
Egypt
Locations

Faculty of Physical Therapy, Badr University
Cairo, New Cairo, Egypt

Mariam El Ebrashy, PhD, Principal Investigator
Badr University in Cairo

Badr University
NCT Number
Keywords
Lung funnctions
Menopause
Obesity
COVID19
MeSH Terms
COVID-19